Atlas Trials

A Comparison Between Two Oral Hypoglycemics - Metformin and Glybenclamide for the Treatment of Gestational Diabetes Mellitus

Clinical trial NCT01563120 · COMPLETED

Trial details

NCT number
NCT01563120
Sponsor
HaEmek Medical Center, Israel
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Gestational Diabetes Mellitus
Start date
2012-01-01
Primary completion
2014-06-01
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.